Objective: Vitamin D status has been implicated in the pathophysiology of heart failure (HF). The aim of this study was to investigate the association between vitamin D levels with heart rate variability and heart rate turbulence in patients with heart failure whom had ischemic and non-ischemic dilated cardiomyopathy. Methods: Study designed as an observational cross-sectional study. Seventy-one patients [36 non-ischemic dilated cardiomyopathy (NIDCM), 35 ischemic dilated cardiomyopathy (IDCM)] with chronic heart failure and 25 control subject were included. It was evaluated the association between 25 hydroxyvitamin D [25(OH)D] and calcitriol levels with heart rate variability time domain (SDNN, SDANN, RMSSD) and heart rate turbulence [turbulence onset (TO), turbulence slope (TS)] parameters. Statistical analysis was performed using Kruskal-Wallis test and ANOVA. Results: Calcitriol levels in NIDCM patients with abnormal TO and TS were significantly lower than NIDCM patients with normal TO (17.1±11.3 vs. 27.6±15.5 pg/mL, p=0.05) and TS (16.6±9.1 vs. 29.4±16.9 pg/mL, p=.018). There was a positive correlation between 25 (OH) D with heart rate variability parameters SDNN (r=0.368, p=0.027) and SDANN (r=0.360, p=0.031). It was not found any association between vitamin D and parameters of heart rate variability and heart rate turbulence in IDCM patients. Conclusion: Insufficiency of vitamin D may have deleterious effects on cardiac autonomic functions which were showed with heart rate turbulence and heart rate variability in patients with NIDCM. Vitamin D levels might be a predictor to determine the sudden cardiac death in patients with non-ischemic etiology. (Anadolu Kardiyol Derg 2014; 14: 434-41) 
Introduction
Congestive heart failure (HF) is a chronic disease that incidence is growing in the population (1) . Despite recent advances in therapy, HF carries an unacceptably high mortality rate (2, 3) . There is an accumulating body of evidence that vitamin D insufficiency is a frequent finding in patients with HF and its insufficiency plays an important role in the etiology and pathogenesis of congestive HF. Low vitamin D status is associated with increased activity of the renin-angiotensin-aldosterone system causing arterial hypertension and myocardial hypertrophy. Inflammatory actions significantly increase with poor vitamin D status . Vitamin D metabolites have direct effects on cardiomyocytes including anti-hypertrophic actions, regulation of extracellular matrix turnover, and modulation of contractility (4) (5) (6) . In addition vitamin D insufficiency has effect on HF prognosis. Several further studies have shown associations of low vitamin D concentrations with cardiovascular events including sudden cardiac death and mortality with HF patients (4, 5, 7, 8) .
Heart rate variability (HRV) (9) (10) (11) and heart rate turbulence (HRT) (12) (13) (14) that reflect cardiac autonomic imbalance have been introduced as useful techniques in identifying patients at high risk for cardiac events including sudden cardiac death with HF. There is not enough data about relationship with vitamin D status and cardiac autonomic function. The aims of this study were to determine whether a low plasma vitamin D levels is associated with an impaired cardiac autonomic functions in patients with HF or not.
Methods
Study design: an observational cross-sectional study.
Patient population
Seventy-one patients with chronic heart failure and 25 healthy controls were included into the study between November 2009-May 2011 at Kocaeli University, Hospital of Medical Faculty. Thirty-six of patients had non-ischemic dilated cardiomyopathy (NIDCM), thirty-five of them had ischemic dilated cardiomyopathy (IDCM). Patients who recruited into the study were hospitalized due to decompensated chronic heart failure. DCM was diagnosed based on left ventricular systolic dysfunction (LVEF ≤45%) and left ventricular dilatation [left ventricular diastolic dimension (LVDD) >55 mm]. Ischemic DCM was determined if any of the following criteria were met: (1) stenosis of a major coronary artery of ≥50% on angiography; (2) a history of percutaneous coronary revascularization; (3) a history of coronary artery bypass graft surgery or (4) a documented history of myocardial infarction. All other etiologies were considered to be non-ischemic. All patients had sinus rhythm, available 24 hours Holter recording, normal blood calcium levels. The bone mineral densitometry was done to determine of the osteoporosis in the study group. Exclusion criteria's were as follows: chronic kidney disease, chronic liver disease, diabetes mellitus, atrial fibrillation, thyroid or parathyroid disease or recent surgery, cancer, using drugs effect on autonomic nervous system and current smokers.
This study conforms to the Declaration of Helsinki, local Ethics Committees approved the study, and all patients provided written informed consent. The clinical characteristics of the patient population are listed in Table 1 .
Vitamin D analysis
Venous blood samples were obtained non-fasting in first three days during the hospitalization. 25 hydroxyvitamin D [25 (OH) D] and its acting form calcitriol were measured. 25 (OH) D was measured in ng/mL by enzyme-linked immunosorbent assay (EIA; Immuno Diagnostic Systems, Boldon, UK). Patients with 25 (OH) D levels ≤20 ng/mL are considered vitamin D insufficient. Calcitriol was measured in pg/mL by enzyme-linked immunosorbent assay (EIA; Immuno Diagnostic Systems, Boldon, UK).
Measurement of heart rate variability Heart rate variability (HRV) was assessed from 24-hour Holter ECGs recordings using previously described and validated methods (15, 16) . Holter recordings were performed after hemodynamic stabilization of patients. Holter recordings were analyzed using the Cardio Navigator Holter system (Del Mar Reynolds Medical Ltd, UK). After the labeling process, the data file was verified, manually over read, and corrected where appropriate. Heart rate variability was analyzed using the HRV analysis module in Cardio Navigator Holter system. For the purposes of this study, 3 different HRV indices were measured: (1) the standard deviation of all normal-to-normal RR intervals (SDNN), (2) the standard deviation of the average normal to normal interval (SDANN) and (3) the square root of the mean of the squares of the differences between adjacent normal-to-normal RR intervals (RMSSD).
Measurement of heart rate turbulence Heart rate turbulence was calculated from the same Holter recordings. HRT was automatically measured using software HRT, view application. HRT parameters included turbulence onset (TO) and turbulence slope (TS), which were determined according to a previously published method (14) (15) (16) (17) . The TO is defined as the difference between the mean of the first two sinus RR intervals after a ventricular premature beat (VPB) and the last two sinus RR intervals before the VPB divided by the mean of the last two RR intervals before the VPB [(RR1 +RR2)-(RR-2 +RR-1)/(RR-2 +RR-1)], thus, expressing the proportional RR interval decrease immediately after the compensatory pause of the VPB. Positive values of TO reflect sinus rhythm deceleration after VPB, whereas negative values indicate acceleration of the sinus rhythm. The TS is defined as the steepest slope of a regression line assessed over any sequence of 5 subsequent RR intervals within the first 15 sinus rhythm intervals after the VPB (unit: ms/RR interval) thus expressing the subsequent RR interval increase. The TO and TS were dichotomized at predefined cut-off points (TO=0%, TS=2.5 ms/RR interval) (14) . HRT abnormal patients defined as when TO or TS were abnormal (TO≥0% or TS≤2.5 ms/RR interval) in this study.
Statistical analysis
The SPSS 13.0 (SPSS Inc., an IBM company; Chicago, Ill) statistical software package was used for statistical analyses. Results are presented as mean±SD or as percentages and numbers for categorical data. Normality tests were used for all variables. Continuous variables that were normally distributed were analyzed with using t-test for Independent samples, and unequally distributed variables were analyzed with MannWhitney U test. To compare values within the 3 groups, a 1-way ANOVA analysis of variance was used and Kruskal-Wallis test was applied for analysis of abnormally distributed variables. Homogeneity of variances was tested for all variables with Levene's test. If equal variances were assumed, Tukey's HSD posthoc test was applied; if not, the Tamhane T2 test was used to compare the parameters within groups. The Bonferroni correction was used to determine statistically significant values among patient groups. Categorical data and proportions were analyzed using the κ 2 . Correlations between 25 (OH) D and calcitriol with other variables were determined by Spearman correlation analysis.
Results
According to baseline characteristics there were no difference with age, sex (NIDCM group; mean age 59±14 years, 22
Çetin et al. Vitamin D levels and chronic heart failure Anadolu Kardiyol Derg 2014; 14: 434-41 male, 14 female, IDCM group; mean age 62±10 years, 26 male, 9 female, control group; mean age 56±9 years, 12 male, 13 female), BMI and sun exposure within three groups. There were no significant differences with other clinical variables between two DCM groups except medications. The number of patients who were using angiotensin-II-antagonist and digoxin were Table 2 . Mean 25 (OH) D levels were lower both in NIDCM (14.3±10.6 ng/mL) and IDCM (15.8±6.5 ng/mL) groups and it was significantly different when compared with control (33.6±14.3 ng/mL) group (p<0.001). 27 (75%) of NIDCM, 25 (71%) of IDCM patient and 4 (16%) of control subjects had deficient levels of 25 (OH) D concentration that described by most guidelines [<20 ng/mL (50 nmoL/L)] (18). Although calcitriol levels of two patients group were lower compared to control group, there were no statistically differences in calcitriol levels within three groups.
Outcome of measurement of HRV and HRT
Comparisons of mean values of HRV and HRT indices in patients and control groups were demonstrated in Table 3 .
Patients with NIDCM and IDCM as compared with control subjects had reduced HRV (SDNN, SDANN and RMSSD). Reduction on SDNN and SDANN indices in both DCM groups were statically significant (p<0.001) when compared with control. Within RMSSD values there was significant difference only between IDCM and control (p<0.05). There were not any differences with HRV indices between DCM groups.
Average TS values were significantly lower in DCM groups compared with control (p<0.001). There were no differences within average TO values. 20 (56%) patient with NIDCM, 15 (43%) patient with IDCM, 3 (12%) of control subjects had abnormal TO, 20 (56%) patient with NIDCM, 20 (57%) patient with IDCM, 1 (4%) of control subjects had abnormal TS, respectively. Abnormal TO and TS ratios were same in DCM groups but significantly more than control group.
Association of vitamin D with HRV and HRT All groups were divided in two subgroups of 25 (OH) D concentration <20 ng/mL and >20 ng/mL. Association between deficiency of 25 (OH) D level and HRV indices were evaluated. In NIDCM patients with 25 (OH) D deficiencies SDNN, SDANN and RMSSD parameters were lower than others but not statistically significant. In IDCM and control groups there were no association with 25 (OH) D levels and HRV. We did not find any statistical Table 4 . There was a positive correlation between 25 (OH) D levels with SDNN (r=0.368, p=0.027), SDANN (r=0.360, p=0.031) and negative correlation with QTc durations (r=-0.340, p=0.042) in patient with NIDCM (Table 5 ). In all groups there was no association of calcitriol with HRV.
Comparison of vitamin D levels with abnormal TO and TS showed that, calcitriol levels were significantly lower in NIDCM patients with abnormal TS (p=0.018) and abnormal TO (p=0.05) than with normal TS and normal TO. There was not same association in IDCM and control groups. 25 (OH) D levels did not show any association with HRT. Details are listed in Table 6 .
Discussion
In this study, as expected the patients with ischemic and non-ischemic DCM had lower levels of 25 (OH) D and the reduced HRV indices (such as SDNN and SDANN) than the control subjects. Although TS values were statistically lower in the patient groups than the control group, TO values were not statistically different among three groups. In patients with NIDCM, 25 (OH) D were positively correlated with SDNN and SDANN. The calcitriol levels in NIDCM patients with abnormal TO and TS were significantly lower than NIDCMP patients with normal TO and TS.
In previous studies it was reported that patients with heart failure had decreased vitamin D levels (19) (20) (21) . The lowest values were between 9.6±5.8 ng/mL and 11.4±6.6 ng/mL determined by Zitterman et al. (19) Our findings confirm and extends the results of previous studies that patients with HF exhibit low vitamin D status.
Recent studies demonstrated the association of low vitamin D concentrations with cardiovascular events and all-cause mortality (4) (5) (6) 22) . However there are only two studies those showed the association of low levels of 25(OH) D and calcitriol level with sudden cardiac death (SCD) (7, 8) . First, Pilz et al. (7) evaluate the risk of SCDs in cohort of the patients who referred for coronary angiography. During median follow-up time of 7. (23) (24) (25) . This notion is in line with the observations in hemodialysis patients showing that calcitriol treatment reduced a prolonged QTc dispersion (23), which is a risk factor for SCD and this relationship might be causal. Our findings supported the positive correlation between 25 (OH) D with QTc, in NIDCM patients.
Our study is the first to highlight the relation between vitamin D deficiency and autonomic imbalance. We demonstrated that, 25 (OH) D and calcitriol were related with HRV and HRT indices that reflect the activity of the autonomic nervous system. NIDCM patients with abnormal HRT had low calcitriol levels and 25 (OH) D levels were positively correlated with HRV. As we know HF is characterized by the autonomic dysfunction that cause increased risk for the arrhythmias, sudden death, and increased mortality (26) (27) (28) (29) (30) . According to our data, low concentrations of vitamin D may have negative effects on autonomic balance and cause ventricular arrhythmias. Association of low levels of vitamin D with autonomic imbalance might be one of the possible causal mechanisms for the pathogenesis of SCD. Interestingly, the risk for the SCD was higher for study partici- pants without coronary artery disease than for those with coronary artery disease observed by Pilz et al. (7) Our results were in line with Pilz et al. (7) This finding may suggest that vitamin D may be more important for the physiology of the cardiomyocytes and less for the coronary circulation. And the vitamin D deficiency could be more closely related to the pathogenesis of "non-ischemic" myocardial diseases compared with those with an ischemic origin. After this study we suggested that; vitamin D status should detect routinely in all NIDCM patients. It could be an easy and simple way to determine the high risk patients. At this point the effects of the treatment with vitamin D on autonomic dysfunction are not known. Witham et al. (31) . showed that, vitamin D replacement has no effect on HRT values during 16 weeks on patients who had previously suffered a stroke. The above mentioned study was the single one with the small population which focused on this topic. A-sixteen week treatment with vitamin D couldn't be enough to observe the treatment effect of vitamin D in patients with low vitamin status. Another point, we do not know yet which vitamin D level is enough to see an effect on HRT in patients with HF. This issue needs more research to find out the best vitamin D levels for this patient population. Our results could not be generalized for all HF patients because of small groups. Presented study could be a trigger for other researches on this topic. It seems that we need to do more researches to understand the effects of vitamin D treatment on autonomic dysfunction with HF patients.
In our study we couldn't observe the same results with the ischemic DCM patients. It was thought that the specific pathogenesis of ischemic DCM might be the reason of this difference. In other words; the relation between vitamin D levels and autonomic function might be disintegrated by common atherosclerosis and inflammation. The medications of two DCM groups were different. It is well known that medication influence HRV and HRT. Beta-blockers inhibit sympathetic activity and improve HRV (32, 33) also angiotensin converting enzym inhibitors and angio- Statistics were done using by қ 2 , in this table. NS -not significant; IDKMP -ischemic dilated cardiomyopathy; NIDCM -non-ischemic dilated cardiomyopathy; SDNN -standard deviation of all normal-to-normal RR intervals; SDANN -standard deviation of the average normal to normal interval; RMSSD -squares of the differences between adjacent normal-to-normal RR intervals; TO -turbulence onset; TS -turbulence slope tensin receptor blockers enhance the vagal stimulations and baroreflex sensitivity so that positively effects HRV and HRT (34, 35) . In our study, the number of patients who were using angiotensin-II antagonist and digoxin were much more in NIDCM group and the number of patients using aspirin, statins and nitrates were much more in IDCM group than the other group. These drugs may change the hemodynamics with the different ways that unknown. Heterogenic distribution of drugs using and their effects might be the other reason of the difference between two DCM groups.
Study limitations
There are several limitations of our study. Firstly, the population size was small because our exclusion criteria. We did not include patients with diabetes chronic kidney disease, atrial fibrillation, thyroid disease and current smokers. Secondly using the less reliable time domain HRV parameters, instead of frequency domain HRV parameter is another limitation Also, we do not have follow-up and mortality data for the patients groups therefore, and additional analyses of the end-points were not performed.
Conclusion
This was the first study which evaluated the relation between the vitamin D status and autonomic function indices as HRV and HRT in patients with DCM. It was shown in this study; the lower vitamin D levels may have deleterious effect on HRT indices in patients with NIDCM. The low vitamin D level could be a trigger for sudden cardiac death in this patient population. This topic needs a lot of research to find out the relation between vitamin D levels and autonomic dysfunction and sudden cardiac death. There is another question to be answered that the appropriate vitamin D level for patients with NIDCM is another question to be answered.
